Infections in patients with diabetes mellitus: A review of pathogenesis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
In general, infectious diseases are more frequent and/or serious in patients with diabetes mellitus, which potentially increases their morbimortality. The greater frequency of infections in diabetic patients is caused by the hyperglycemic environment that favors immune dysfunction (e.g., damage to the neutrophil function, depression of the antioxidant system, and humoral immunity), micro- and macro-angiopathies, neuropathy, decrease in the antibacterial activity of urine, gastrointestinal and urinary dysmotility, and greater number of medical interventions in these patients. The infections affect all organs and systems. Some of these problems are seen mostly in diabetic people, such as foot infections, malignant external otitis, rhinocerebral mucormycosis, and gangrenous cholecystitis. In addition to the increased morbidity, infectious processes may be the first manifestation of diabetes mellitus or the precipitating factors for complications inherent to the disease, such as diabetic ketoacidosis and hypoglycemia. Immunization with anti-pneumococcal and influenza vaccines is recommended to reduce hospitalizations, deaths, and medical expenses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Immune dysfunction in patients with diabetes mellitus (DM)
Geerlings, S. (1999) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(99)00142-x · Cited by 1,272
Infections in Patients with Diabetes Mellitus
Joshi, N., Caputo, G. M., Weitekamp, M. R., & Karchmer, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412507 · Cited by 1,043
Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus
Muller, L. M. A. J., Gorter, K. J., Hak, E., Goudzwaard, W. L., Schellevis, F. G., Hoepelman, A. I. M., & Rutten, G. E. H. M. (2005) · Clinical Infectious Diseases · doi:10.1086/431587 · Cited by 1,023
Centers for Disease Control and Prevention (CDC)
(2011) · Encyclopedia of Disaster Relief · doi:10.4135/9781412994064.n25 · Cited by 1,021
Tuberculosis and diabetes mellitus: convergence of two epidemics
Dooley, K. E., & Chaisson, R. E. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70282-8 · Cited by 932
Common infections in diabetes: Pathogenesis, management and relationship to glycaemic control
Peleg, A. Y., Weerarathna, T., McCarthy, J. S., & Davis, T. M. E. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.682 · Cited by 584 · cited 10×
“Antibodies Glycation of immunoglobulin occurs in patients with diabetes in proportion with the increase in HbA1c, and this may harm the biological function of the antibodies.[4] However, the clinical relevance of these observations is not clear, since the response of antibodies after vaccination and to common infectio…”
BackgroundInfluentialRelationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Rayner, C. K., Samsom, M., Jones, K. L., & Horowitz, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.371 · Cited by 460
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
Liu, M., Spellberg, B., Phan, Q. T., Fu, Y., Fu, Y., Lee, A. S., Edwards, J. E., Filler, S. G., & Ibrahim, A. S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42164 · Cited by 324
Cited by
Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science · doi:10.1126/science.aar3318 · Cited by 942
Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc17-2131 · Cited by 604
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
The Effect of Short-Term Hyperglycemia on the Innate Immune System
Jafar, N., Edriss, H., & Nugent, K. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2015.11.011 · Cited by 463
Critchley, J. A., Carey, I. M., Harris, T., DeWilde, S., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc18-0287 · Cited by 391
Epidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351
“Comorbidities for sepsis and severe viral infection such as diabetes mellitus (116), renal failure (117, 118) chronic obstructive pulmonary disease (117, 119), heart conditions (120), and obesity (120, 121) are much more prevalent in older adult populations.”
BackgroundAssociation between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis
Al-Rifai, R. H., Pearson, F., Critchley, J. A., & Abu-Raddad, L. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187967 · Cited by 310
Diabetes and infection: assessing the association with glycaemic control in population-based studies
Pearson-Stuttard, J., Blundell, S., Harris, T., Cook, D. G., & Critchley, J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00379-4 · Cited by 308
A metabolic handbook for the COVID-19 pandemic
Ayres, J. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0237-2 · Cited by 292
Systemic inflammation after stroke: implications for post‐stroke comorbidities
Simats, A., & Liesz, A. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216269 · Cited by 276
Evaluating All Potential Oral Complications of Diabetes Mellitus
Verhulst, M. J. L., Loos, B. G., Gerdes, V. E. A., & Teeuw, W. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00056 · Cited by 276
Syed, F. Z. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202203150 · Cited by 255
Li, D., Wang, T., Shen, S., Fang, Z., Dong, Y., & Tang, H. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12825 · Cited by 253
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
Stubbs, B. J., Koutnik, A. P., Goldberg, E. L., Upadhyay, V., Turnbaugh, P. J., Verdin, E., & Newman, J. C. (2020) · Med · doi:10.1016/j.medj.2020.06.008 · Cited by 71
Ferretti, F., Cannatelli, R., Benucci, M., Carmagnola, S., Clementi, E., Danelli, P., Dilillo, D., Fiorina, P., Galli, M., Gallieni, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656362 · Cited by 39
“Altered immune functions, as of chemotaxis, phagocytosis and cytokines secretion, are among the proposed mechanisms (94).”
BackgroundMohammed, L., Jha, G., Malasevskaia, I., Goud, H. K., & Hassan, A. (2021) · Cureus · doi:10.7759/cureus.13407 · Cited by 35
“Figure 2 depicts the reasons for the greater susceptibility of diabetics to infections [11].”
BackgroundSeo, Y. B., Baek, J. H., Lee, J., Song, J. Y., Lee, J. S., Cheong, H. J., & Kim, W. J. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00288-15 · Cited by 32
Risk of infection in older adults with type 2 diabetes with relaxed glycemic control
Lipska, K. J., Gilliam, L. K., Lee, C., Liu, J. Y., Liu, V. X., Moffet, H. H., Parker, M. M., Zapata, H., & Karter, A. J. (2024) · Diabetes Care · doi:10.2337/dc24-1612 · Cited by 7
Metadata
- Authors
- Alves, C., Casqueiro, J., & Casqueiro, J.
- Venue
- Indian Journal of Endocrinology and Metabolism
- Publisher
- Medknow
- Published
- 2012
- Volume
- 16
- Issue
- 7
- Pages
- 27
- ISSN
- 2230-8210 (ISSN-L)
- OpenAlex
- W1979281993
- Cited by
- 1,147
- References
- 55
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.